China is positioning itself as a global frontrunner in the brain-computer interface (BCI) market, and this week it achieved a historic milestone. Chinese neurotechnology firm Neuracle—also known as Borui Kang Medical Technology—successfully performed the world’s first surgical implant of a commercial BCI device in a human patient, a breakthrough reported by multiple Chinese news outlets on Wednesday.

A Coin-Sized Window Into the Brain

The device, called Neural Electronic Opportunity, or NEO, is roughly the size of a coin and contains eight electrodes. It was surgically placed onto the surface of the patient’s sensorimotor cortex, the region of the brain responsible for voluntary movement. The patient, who lost mobility in his hand following a spinal cord injury a decade ago, can now command a robotic glove simply by imagining the movement. NEO records the electrical signals fired between neurons as the patient thinks about moving his hand, sends those signals to a computer, and the computer translates them into motor commands that drive the glove.

NEO received approval from China’s National Medical Products Administration in March, making it the first invasive BCI ever authorized for commercial use by a national regulatory agency anywhere in the world.

Racing Against Neuralink

Neuracle’s achievement intensifies the global race for BCI supremacy, with the Chinese company directly competing against Elon Musk’s Neuralink. Neuralink successfully implanted its first BCI in a human patient in 2024, though that was not the first-ever successful BCI implant. However, Neuralink has yet to receive approval from the U.S. Food and Drug Administration, a prerequisite for bringing new medical devices to market in America. Musk’s company stated earlier this year that it had enrolled twenty-one people in clinical trials.

While both Neuracle and Neuralink have pursued surgical implants—which carry inherent risks—other companies are exploring less invasive approaches. Last month, Meta unveiled an updated version of its Brain2Qwerty system, which uses a large language model to translate brain activity into written text, potentially helping patients with ALS and other neurodegenerative conditions communicate again. Another Chinese firm, BrainCo, has developed a bionic prosthetic hand driven by AI and electromyography.

A National Priority

China’s push into BCIs is not just corporate ambition—it is state policy. The technology was named a core priority in the Chinese government’s latest five-year plan, alongside quantum computing, AI-powered robotics, nuclear fusion, and other strategic technologies, according to Reuters. The country is investing heavily in domestic BCI research and development as part of a broader effort to close the gap with the United States in cutting-edge technology.

With NEO now implanted and operational, Neuracle has opened a new chapter in the commercialization of brain-computer interfaces. While questions about long-term safety, data privacy, and regulatory oversight remain, the procedure represents a tangible step toward a future in which the boundaries between the human brain and external machines become increasingly blurred. The world will be watching closely as both China and the U.S. continue their high-stakes push to define that future.